Shaker Investments’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.8M Buy
81,641
+21,601
+36% +$1.97M 2.8% 8
2026
Q1
$5.78M Sell
60,040
-2,205
-4% -$221K 2.63% 8
2025
Q4
$6.06M Sell
62,245
-954
-2% -$81.8K 2.52% 12
2025
Q3
$4.5M Buy
63,199
+10,056
+19% +$670K 1.8% 15
2025
Q2
$3.18M Buy
53,143
+9,580
+22% +$525K 1.3% 29
2025
Q1
$2.29M Buy
43,563
+13,669
+46% +$768K 1.1% 33
2024
Q4
$1.64M Buy
29,894
+233
+0.8% +$12.3K 0.69% 46
2024
Q3
$1.49M Buy
29,661
+9,056
+44% +$418K 0.62% 54
2024
Q2
$905K Buy
20,605
+347
+2% +$14.8K 0.39% 63
2024
Q1
$891K Buy
20,258
+258
+1% +$11.4K 0.38% 66
2023
Q4
$949K Buy
20,000
+7,081
+55% +$298K 0.44% 59
2023
Q3
$573K Buy
12,919
+5,609
+77% +$261K 0.32% 67
2023
Q2
$349K Buy
+7,310
New +$330K 0.18% 82

Other funds holding IRMD

Shaker Investments's IRMD Position: Q2 2026 in Review

Shaker Investments increased its iRadimed (IRMD) stake by 36% in Q2 2026, buying an estimated $1.97M and bringing the position to 81,641 shares worth $7.8M. The position accounts for 2.8% of the portfolio, ranked #8.

Shaker Investments first reported a position in IRMD in Q2 2023 and has held it in 13 quarters since. 18 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Shaker Investments held 81,641 shares of iRadimed worth $7.8M as of Q2 2026.
  • Shaker Investments bought 21,601 iRadimed shares in Q2 2026, an estimated $1.97M.
  • iRadimed made up 2.8% of Shaker Investments's portfolio in Q2 2026, its #8 holding.
  • Shaker Investments first reported a position in iRadimed in Q2 2023 and has held it in 13 quarters since.
  • 18 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Shaker Investments's 13F filing for Q2 2026, filed 15 Jul 2026.